|
AP9528a-ev
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
|
AP9528a
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
|
AP9856c-ev
|
Abcepta, Inc.
|
K2C78 [Centre] [RB24916], Rabbit Polyclonal Antibody
|
Human
|
FC, WB
|
|
|
AP9856c
|
Abcepta, Inc.
|
K2C78 [Centre] [RB24916], Rabbit Polyclonal Antibody
|
Human
|
FC, WB
|
|
|
AP19254b-ev
|
Abcepta, Inc.
|
TMED10 [C-term] [RB40979], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP19254b
|
Abcepta, Inc.
|
TMED10 [C-term] [RB40979], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP16626c-ev
|
Abcepta, Inc.
|
TMED6 [Centre] [RB36101], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP16626c
|
Abcepta, Inc.
|
TMED6 [Centre] [RB36101], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AM2262b-ev
|
Abcepta, Inc.
|
VCP [1344CT150.163.114], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
IF, WB
|
|
|
AM2262b
|
Abcepta, Inc.
|
VCP [1344CT150.163.114], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
IF, WB
|
|
|
AM8494b-ev
|
Abcepta, Inc.
|
VCP [1563CT163.48.77], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB, IHC-P, FC, IF
|
|
|
AM8494b
|
Abcepta, Inc.
|
VCP [1563CT163.48.77], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB, IHC-P, FC, IF
|
|
|
HY-138633-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
|
HY-138633-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
|
HY-138633-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
|
HY-138633-1mL
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-138634-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-11
|
|
Cancer-programmed cell death
|
|
|
HY-138634-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-11
|
|
Cancer-programmed cell death
|
|
|
HY-138634-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-11
|
|
Cancer-programmed cell death
|
|
|
HY-138634-1mL
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-11 [CAS ] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-138635-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
|
HY-138635-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
|
HY-138635-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
|
HY-138635-1mL
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-138632-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
